Alphatec Holdings (ATEC) stock plummeted 5.06% in the pre-market trading session on Thursday, following the company's fourth-quarter 2024 earnings call where it provided guidance for the upcoming year.
During the earnings call, Alphatec projected revenue growth of 20% for 2025, which came in lower than analysts' expectations. The company forecasted revenue of approximately $732 million for the year, including surgical revenue growth of 21% to around $657 million.
While Alphatec reported strong fourth-quarter results, with revenue growing 28% year-over-year and adjusted EBITDA reaching $21 million, investors seemed concerned about the company's outlook for the coming year. The projected revenue growth rate of 20% was viewed as disappointing, especially in light of the company's recent performance and the disruptions in the spine surgery market.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。